Adriana is an observer on Nested’s Board of Directors. She currently serves as Vice President of Life Sciences Investing at Goldman Sachs, where she specializes in evaluating and facilitating investments in life sciences companies. Most recently, she served as Head of External Innovation at insitro, a biotechnology company applying machine learning to drug discovery. Previously, she was a Principal at The Column Group, where she supported company-formation efforts in innovative therapeutics companies, building on her prior experience at QB3, a leading life science entrepreneurship institute at the University of California San Francisco. Adriana has also served on the boards of A2 Biotherapeutics, Accent Therapeutics and Carmot Therapeutics. She earned her Ph.D. in Stem Cell and Regenerative Biology from Harvard and her B.S. in Biology from MIT.